Kv1.3 Channel Blockade Improves Inflammatory Profile, Reduces Cardiac Electrical Remodeling, and Prevents Arrhythmia in Type 2 Diabetic Rats.
Julián Zayas-ArrabalAmaia AlquizaAinhoa Rodríguez-de-YurreLeyre EcheazarraVíctor Fernández-LópezMónica GallegoÓscar CasisPublished in: Cardiovascular drugs and therapy (2021)
Kv1.3 inhibition improves diabetes and diabetes-associated low-grade inflammation and cardiac electrical remodeling, resulting in more protection against cardiac arrhythmia compared to metformin.